Literature DB >> 16405865

Merlin inhibits growth hormone-regulated Raf-ERKs pathways by binding to Grb2 protein.

Jung Yeon Lim1, Hongtae Kim, Sin-Soo Jeun, Seok-Gu Kang, Kyung-Jin Lee.   

Abstract

Numerous studies have suggested that the NF2 protein merlin is involved in the regulation of abnormal cell growth and proliferation. In this study, to better understand the merlin's mechanisms that contribute to the inhibition of tumorigenesis, we examined the potential action of merlin on the cell proliferative signaling pathways in response to growth hormone (GH). Merlin effectively attenuated the GH-induced serum response element (SRE) and Elk-1-mediated transcriptional activation, as well as the endogenous SRE-regulated gene c-fos expression in NIH3T3 cells. In addition, merlin prevented the Raf-1 complex activation process, which resulted in the suppression of MAP kinase/ERK, extracellular signal-regulated kinase (ERKs), and Elk-1 phosphorylation, which are the downstream signals of Raf-1. Moreover, it was shown that merlin interacted with endogenous growth factor receptor bound 2 (Grb2) protein and inhibited its expression. These results suggest that merlin contributes, via its protein-to-protein interaction with Grb2 and consequent inhibition of the MAPK pathways, to the regulation of the abnormal cell proliferation, and this provides a further mechanism underlying the tumor suppressor function of merlin.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16405865     DOI: 10.1016/j.bbrc.2005.12.122

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  10 in total

Review 1.  Neurofibromatosis type 2.

Authors:  Ashok R Asthagiri; Dilys M Parry; John A Butman; H Jeffrey Kim; Ekaterini T Tsilou; Zhengping Zhuang; Russell R Lonser
Journal:  Lancet       Date:  2009-05-22       Impact factor: 79.321

2.  Inhibition of Cdc42-mediated activation of mixed lineage kinase 3 by the tumor suppressor protein merlin.

Authors:  Yu Zhan; Deborah N Chadee
Journal:  Small GTPases       Date:  2010-11

Review 3.  Merlin, a "magic" linker between extracellular cues and intracellular signaling pathways that regulate cell motility, proliferation, and survival.

Authors:  Ivan Stamenkovic; Qin Yu
Journal:  Curr Protein Pept Sci       Date:  2010-09       Impact factor: 3.272

4.  The neurofibromatosis 2 protein, merlin, regulates glial cell growth in an ErbB2- and Src-dependent manner.

Authors:  S Sean Houshmandi; Ryan J Emnett; Marco Giovannini; David H Gutmann
Journal:  Mol Cell Biol       Date:  2008-12-22       Impact factor: 4.272

5.  The ErbB inhibitors trastuzumab and erlotinib inhibit growth of vestibular schwannoma xenografts in nude mice: a preliminary study.

Authors:  J Jason Clark; Matthew Provenzano; Henry R Diggelmann; Ningyong Xu; Skylar S Hansen; Marlan R Hansen
Journal:  Otol Neurotol       Date:  2008-09       Impact factor: 2.311

6.  Deducing corticotropin-releasing hormone receptor type 1 signaling networks from gene expression data by usage of genetic algorithms and graphical Gaussian models.

Authors:  Dietrich Trümbach; Cornelia Graf; Benno Pütz; Claudia Kühne; Marcus Panhuysen; Peter Weber; Florian Holsboer; Wolfgang Wurst; Gerhard Welzl; Jan M Deussing
Journal:  BMC Syst Biol       Date:  2010-11-19

Review 7.  NF2/merlin in hereditary neurofibromatosis 2 versus cancer: biologic mechanisms and clinical associations.

Authors:  Rebecca Dunbar Schroeder; Laura S Angelo; Razelle Kurzrock
Journal:  Oncotarget       Date:  2014-01-15

8.  Novel age-dependent targets in vestibular schwannomas.

Authors:  Amos Toren; Juergen K Reichardt; Ali Andalibi; Nancy Ya-Hsuan Hsu; Joni Doherty; William Slattery; Ruty Mehrian-Shai
Journal:  Hum Genomics       Date:  2014-06-30       Impact factor: 4.639

9.  The NF2 tumor suppressor merlin interacts with Ras and RasGAP, which may modulate Ras signaling.

Authors:  Yan Cui; Susann Groth; Scott Troutman; Annemarie Carlstedt; Tobias Sperka; Lars Björn Riecken; Joseph L Kissil; Hongchuan Jin; Helen Morrison
Journal:  Oncogene       Date:  2019-07-16       Impact factor: 9.867

Review 10.  Neurofibromatosis Type 2 (NF2) and the Implications for Vestibular Schwannoma and Meningioma Pathogenesis.

Authors:  Suha Bachir; Sanjit Shah; Scott Shapiro; Abigail Koehler; Abdelkader Mahammedi; Ravi N Samy; Mario Zuccarello; Elizabeth Schorry; Soma Sengupta
Journal:  Int J Mol Sci       Date:  2021-01-12       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.